Comparison of outcomes in augmentation naïve and augmented patients with alpha-1 antitrypsin deficiency related lung disease.

P. Ellis (Birmingham, United Kingdom), K. Holm (Denver, United States of America), R. Choate (Lexington, United States of America), D. Mannino (Lexington, United States of America), R. Stockley (Birmingham, United Kingdom), R. Sandhaus (Denver, United States of America), A. Turner (Birmingham, United Kingdom)

Source: International Congress 2019 – COPD clinical studies: bronchodilators, corticosteroids and more
Session: COPD clinical studies: bronchodilators, corticosteroids and more
Session type: Poster Discussion
Number: 3383

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Ellis (Birmingham, United Kingdom), K. Holm (Denver, United States of America), R. Choate (Lexington, United States of America), D. Mannino (Lexington, United States of America), R. Stockley (Birmingham, United Kingdom), R. Sandhaus (Denver, United States of America), A. Turner (Birmingham, United Kingdom). Comparison of outcomes in augmentation naïve and augmented patients with alpha-1 antitrypsin deficiency related lung disease.. 3383

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: